CAS 269730-03-2

2H-Indol-2-one,1,3-dihydro-3-[(4-hydroxyphenyl)methylene]-5,6-dimethoxy-

Description:

2H-Indol-2-one, 1,3-dihydro-3-[(4-hydroxyphenyl)methylene]-5,6-dimethoxy- is a complex organic compound characterized by its indole structure, which is a bicyclic compound consisting of a benzene ring fused to a pyrrole ring. This particular compound features a methylene bridge connecting a 4-hydroxyphenyl group, contributing to its potential biological activity. The presence of two methoxy groups at the 5 and 6 positions of the indole ring enhances its lipophilicity and may influence its interaction with biological targets. The compound is likely to exhibit various properties, including potential antioxidant, anti-inflammatory, or anticancer activities, which are common in indole derivatives. Its solubility, stability, and reactivity can vary based on the functional groups present and the overall molecular structure. As with many organic compounds, its behavior in biological systems and potential applications in pharmaceuticals or materials science would require further investigation through experimental studies.

Formula: C₁₇H₁₅NO₄

RPI 1

CAS: 269730-03-2

Formula: C₁₇H₁₅NO₄

Purity: >95.0%(HPLC)

Color and Shape: Light yellow to Brown powder to crystal

Molecular weight: 297.31

Ref: 3B-R0202

RPI-1

CAS: 269730-03-2

Formula: C₁₇H₁₅NO₄

Purity: 99%

Color and Shape: Solid

Molecular weight: 297.3053

Ref: IN-DA00BG8H

RPI-1

CAS: 269730-03-2

RPI-1

Purity: ≥95%

Molecular weight: 297.31g/mol

Ref: 54-BUP06298

RPI-1

CAS: 269730-03-2

RPI-1 is a competitive, potent ATP-dependent Ret kinase inhibitor.

Formula: C₁₇H₁₅NO₄

Purity: 98.91% - ≥95%

Color and Shape: Solid

Molecular weight: 297.31

Ref: TM-T2282

RPI-1

CAS: 269730-03-2

RPI-1 is a cytostatic agent that inhibits the proliferation of tumor cells. It has been shown to have synergistic effects with other agents and can be used in combination therapy for cancer treatment. RPI-1 is able to inhibit the growth of cells in tissue culture and to prevent insect resistance by interfering with their ability to synthesize proteins. This drug also has an effect on liver cells, which may be due to its ability to inhibit angiogenic factors. RPI-1 binds to DNA polymerase and prevents transcription by binding to ribonucleotide reductase, blocking RNA synthesis. This active form also inhibits basic fibroblast activity and microvessel density. RPI-1 also has diploid activity, meaning it can bind to both strands of DNA at the same time, which may lead to cell lysis.

Formula: C₁₇H₁₅NO₄

Purity: Min. 95%

Molecular weight: 297.31 g/mol

Ref: 3D-UKA73003